Literature DB >> 15649282

Association of lung function with atherosclerotic risk factors among Japanese Americans: Seattle Nikkei Health Study.

Kenichiro Taneda1, Tsukasa Namekata, Deborah Hughes, Kenji Suzuki, Robert Knopp, Kotaro Ozasa.   

Abstract

1. Impaired lung function has been reported to be associated with mortality from all causes, cardiovascular disease (CVD) and aortic pulse wave velocity (PWV). The aim of the present study was to examine the association between impaired lung function and atherosclerotic risk factors, including PWV, blood pressure, lipids, smoking and alcohol intake, among Japanese Americans. 2. The study subjects were 678 adult Japanese Americans who participated in CVD screening conducted under the Seattle Nikkei Health Study. Subjects with abnormal lung function were defined as those with forced vital capacity (FVC%) < 80% of predicted or forced expiratory volume in 1 s (FEV1%) < 80% of predicted. We conducted logistic regression analyses by using abnormal lung function as dependent variables. 3. The significant predictors positively associated with abnormal FVC% were age (60 years or older) and hypertension. Being a current drinker or an ex-drinker was independently and negatively associated with abnormal FVC%. The significant predictors positively associated with abnormal FEV1% were age (60 years or older), sex (male), hypertension and being a current smoker. Being a current drinker was independently and negatively associated with abnormal FEV1%. 4. In conclusion, the present study does not support the previously reported association of abnormal lung function with PWV. However, our findings imply that light and moderate drinking may be a protective factor of lung function and that hypertension and smoking may impair lung function.

Entities:  

Mesh:

Year:  2004        PMID: 15649282     DOI: 10.1111/j.1440-1681.2004.04116.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  8 in total

1.  Pulmonary function is associated with distal aortic calcium, not proximal aortic distensibility. MESA lung study.

Authors:  David A McAllister; William MacNee; Daniel Duprez; Eric A Hoffman; Jens Vogel-Claussen; Michael H Criqui; Matthew Budoff; Rui Jiang; David A Bluemke; R Graham Barr
Journal:  COPD       Date:  2011-04       Impact factor: 2.409

2.  RNA-seq analysis of lung adenocarcinomas reveals different gene expression profiles between smoking and nonsmoking patients.

Authors:  Yafang Li; Xiangjun Xiao; Xuemei Ji; Bin Liu; Christopher I Amos
Journal:  Tumour Biol       Date:  2015-06-17

Review 3.  Cardiovascular injury and repair in chronic obstructive pulmonary disease.

Authors:  William Macnee; John Maclay; David McAllister
Journal:  Proc Am Thorac Soc       Date:  2008-12-01

4.  Pulmonary Function and Arterial Stiffness in Chronic Heart Failure.

Authors:  Li Li; Bangchuan Hu; Shijin Gong; Yihua Yu; Haiwen Dai; Jing Yan
Journal:  Biomed Res Int       Date:  2016-12-21       Impact factor: 3.411

5.  Age and cigarette smoking modulate the relationship between pulmonary function and arterial stiffness in heart failure patients.

Authors:  Li Li; Bangchuan Hu; Shijin Gong; Yihua Yu; Jing Yan
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  Relationship between pulmonary function and peripheral vascular function in older Chinese: Guangzhou biobank cohort study-CVD.

Authors:  Jing Pan; Lin Xu; Tai Hing Lam; Chao Qiang Jiang; Wei Sen Zhang; Feng Zhu; Ya Li Jin; G Neil Thomas; Kar Keung Cheng; Peymane Adab
Journal:  BMC Pulm Med       Date:  2018-05-21       Impact factor: 3.317

7.  Prevalence and risk factors of asymptomatic peripheral arterial disease in patients with COPD in Taiwan.

Authors:  Ming-Shian Lin; Kun-Yen Hsu; Yi-Jen Chen; Cheng-Ren Chen; Chuan-Mu Chen; Wei Chen
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

8.  Does Poorer Pulmonary Function Accelerate Arterial Stiffening?: A Cohort Study With Repeated Measurements of Carotid-Femoral Pulse Wave Velocity.

Authors:  Masaki Okamoto; Martin J Shipley; Ian B Wilkinson; Carmel M McEniery; Carlos A Valencia-Hernández; Archana Singh-Manoux; Mika Kivimaki; Eric J Brunner
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.